|
1
|
Yoder N, Tal R and Martin JR: Abdominal
ectopic pregnancy after in vitro fertilization and single embryo
transfer: A case report and systematic review. Reprod Biol
Endocrinol. 14:692016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bulun SE: Endometriosis. N Engl J Med.
360:268–279. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dinulescu DM, Ince TA, Quade BJ, Shafer
SA, Crowley D and Jacks T: Role of K-ras and Pten in the
development of mouse models of endometriosis and endometrioid
ovarian cancer. Nat Med. 11:63–70. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Greene AD, Lang SA, Kendziorski JA,
Sroga-Rios JM, Herzog TJ and Burns KA: Endometriosis: Where are we
and where are we going? Reproduction. 152:R63–R78. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maruyama T and Yoshimura Y: Stem cell
theory for the pathogenesis of endometriosis. Front Biosci.
4:2754–2763. 2012. View
Article : Google Scholar
|
|
6
|
Sasson IE and Taylor HS: Stem cells and
the pathogenesis of endometriosis. Ann N Y Acad Sci. 1127:106–115.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kao AP, Wang KH, Chang CC, Lee JN, Long
CY, Chen HS, Tsai CF, Hsieh TH and Tsai EM: Comparative study of
human eutopic and ectopic endometrial mesenchymal stem cells and
the development of an in vivo endometriotic invasion model. Fertil
Steril. 95:1308–1315. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Groothuis PG, Nap AW, Winterhager E and
Grümmer R: Vascular development in endometriosis. Angiogenesis.
8:147–156. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Teague EM, Print CG and Hull ML: The role
of microRNAs in endometriosis and associated reproductive
conditions. Hum Reprod Update. 16:142–165. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zou Y, Guo CG and Zhang MM: Inhibition of
human hepatocellular carcinoma tumor angiogenesis by siRNA
silencing of VEGF via hepatic artery perfusion. Eur Rev Med
Pharmacol Sci. 19:4751–4761. 2015.PubMed/NCBI
|
|
11
|
Liu B, Ding JF, Luo J, Lu L, Yang F and
Tan XD: Seven protective miRNA signatures for prognosis of cervical
cancer. Oncotarget. 7:56690–56698. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cho S, Mutlu L, Grechukhina O and Taylor
HS: Circulating microRNAs as potential biomarkers for
endometriosis. Fertil Steril. 103:1252–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Toloubeydokhti T, Pan Q, Luo X, Bukulmez O
and Chegini N: The expression and ovarian steroid regulation of
endometrial micro-RNAs. Reprod Sci. 15:993–1001. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Braza-Boïls A, Salloum-Asfar S,
Marí-Alexandre J, Arroyo AB, González-Conejero R, Barceló-Molina M,
García-Oms J, Vicente V, Estellés A, Gilabert-Estellés and Martínez
C: Peritoneal fluid modifies the microRNA expression profile in
endometrial and endometriotic cells from women with endometriosis.
Hum Reprod. 30:2292–2302. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li
Y, Li Z, Ng SS, Sung JJ, et al: miR-34a-5p suppresses colorectal
cancer metastasis and predicts recurrence in patients with stage
II/III colorectal cancer. Oncogene. 34:4142–4152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Scognamiglio I, Di Martino MT, Campani V,
Virgilio A, Galeone A, Gullà A, Cantafio ME Gallo, Misso G,
Tagliaferri P, Tassone P, et al: Transferrin-conjugated SNALPs
encapsulating 2′-O-methylated miR-34a for the treatment of multiple
myeloma. Biomed Res Int. Biomed Res Int. 2014:2173652014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Di Martino MT, Campani V, Misso G,
Cantafio ME Gallo, Gullà A, Foresta U, Guzzi PH, Castellano M,
Grimaldi A, Gigantino V, et al: In vivo activity of miR-34a mimics
delivered by stable nucleic acid lipid particles (SNALPs) against
multiple myeloma. PLoS One. 9:e900052014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Misso G, Di Martino MT, De Rosa G, Farooqi
AA, Lombardi A, Campani V, Zarone MR, Gullà A, Tagliaferri P,
Tassone P and Caraglia M: Mir-34: A new weapon against cancer? Mol
Ther Nucleic Acids. 3:e1942014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song P, Ye LF, Zhang C, Peng T and Zhou
XH: Long non-coding RNA XIST exerts oncogenic functions in human
nasopharyngeal carcinoma by targeting miR-34a-5p. Gene. 592:8–14.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li XY, Wen JY, Jia CC, Wang TT, Li X, Dong
M, Lin QU, Chen ZH, Ma XK, Wei LI, et al: MicroRNA-34a-5p enhances
sensitivity to chemotherapy by targeting AXL in hepatocellular
carcinoma MHCC-97 L cells. Oncol Lett. 10:2691–2698.
2015.PubMed/NCBI
|
|
21
|
Ma ZB, Kong XL, Cui G, Ren CC, Zhang YJ,
Fan SJ and Li YH: Expression and clinical significance of miRNA-34a
in colorectal cancer. Asian Pac J Cancer Prev. 15:9265–9270. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Walton SJ, Lewis A, Jeffery R, Thompson H,
Feakins R, Giannoulatou E, Yau C, Lindsay JO, Clark SK and Silver
A: Familial adenomatous patients with desmoid tumours show
increased expression of miR-34a in serum and high levels in
tumours. Oncoscience. 3:173–185. 2016.PubMed/NCBI
|
|
23
|
Lu H, Hao L, Li S, Lin S, Lv L, Chen Y,
Cui H, Zi T, Chu X, Na L and Sun C: Elevated circulating stearic
acid leads to a major lipotoxic effect on mouse pancreatic beta
cells in hyperlipidaemia via a miR-34a-5p-mediated
PERK/p53-dependent pathway. Diabetologia. 59:1247–1257. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Goel HL and Mercurio AM: VEGF targets the
tumour cell. Nat Rev Cancer. 13:871–882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li YZ, Wang LJ, Li X, Li SL, Wang JL, Wu
ZH, Gong L and Zhang XD: Vascular endothelial growth factor gene
polymorphisms contribute to the risk of endometriosis: An updated
systematic review and meta-analysis of 14 case-control studies.
Genet Mol Res. 12:1035–1044. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ramón LA, Braza-Boïls A, Gilabert-Estellés
J, Gilabert J, España F, Chirivella M and Estellés A: MicroRNAs
expression in endometriosis and their relation to angiogenic
factors. Hum Reprod. 26:1082–1090. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang D, Zhou J and Dong M: Dysregulation
of microRNA-34a expression in colorectal cancer inhibits the
phosphorylation of FAK via VEGF. Dig Dis Sci. 59:958–967. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng J, Chen Y, Zhao P, Liu X, Dong J, Li
J, Huang C, Wu R and Lv Y: Downregulation of miRNA-638 promotes
angiogenesis and growth of hepatocellular carcinoma by targeting
VEGF. Oncotarget. 7:30702–30711. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ueno K, Samura M, Nakamura T, Tanaka Y,
Takeuchi Y, Kawamura D, Takahashi M, Hosoyama T, Morikage N and
Hamano K: Increased plasma VEGF levels following ischemic
preconditioning are associated with downregulation of miRNA-762 and
miR-3072-5p. Sci Rep. 6:367582016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim SH, Choi YM, Chae HD, Kim CH and Kang
BM: Decreased expression of angiogenin in the eutopic endometrium
from women with advanced stage endometriosis. J Korean Med Sci.
23:802–807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Finn NA and Searles CD: Intracellular and
extracellular miRNAs in regulation of angiogenesis signaling. Curr
Angiogenes. 4:299–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hsu CY, Hsieh TH, Tsai CF, Tsai HP, Chen
HS, Chang Y, Chuang HY, Lee JN, Hsu YL and Tsai EM: miRNA-199a-5p
regulates VEGFA in endometrial mesenchymal stem cells and
contributes to the pathogenesis of endometriosis. J Pathol.
232:330–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu X, Er K, Mao C, Yan Q, Xu H, Zhang Y,
Zhu J, Cui F, Zhao W and Shi H: miR-203 suppresses tumor growth and
angiogenesis by targeting VEGFA in cervical cancer. Cell Physiol
Biochem. 32:64–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
